Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

FDA advisory committee deems ACEL-IMUNE safe and effective for use in infants

Nov. 8, 1996

ImClone licenses NIH patent for stem cell and gene therapy

Nov. 8, 1996

Bacterial meningitis virtually eliminated in U.S. following introduction of Hib vaccine

Nov. 8, 1996

Novel DNA vaccine induces immune response to HSV-2

Nov. 1, 1996

StressGen's core technology receives patent protection

Nov. 1, 1996

Three-dimensional structure of the T-cell receptor determined

Nov. 1, 1996

Takeda discloses vaccine candidates

Nov. 1, 1996

AM-94 available for licensing

Oct. 25, 1996

AM-101 available for licensing

Oct. 25, 1996

Procept seeks partners for immunosuppression, AIDS, CD2 programs

Oct. 25, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 19, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...